scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VACCINE.2016.01.002 |
P698 | PubMed publication ID | 26795366 |
P50 | author | Nevil Pierse | Q57334808 |
Heath A. Kelly | Q117653221 | ||
Kylie S Carville | Q56810080 | ||
P2093 | author name string | C R Lane | |
P2860 | cites work | Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study | Q59617109 |
Safety and effectiveness of influenza vaccines | Q85948363 | ||
I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe | Q28742719 | ||
Working towards a simple case definition for influenza surveillance. | Q30333094 | ||
Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. | Q30401633 | ||
Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010 | Q30404923 | ||
Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1)pdm09; Germany, 2007-2011 | Q30424769 | ||
Estimation of influenza vaccine effectiveness from routine surveillance data | Q33424462 | ||
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates | Q33554684 | ||
Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008 | Q33931144 | ||
Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons | Q34393525 | ||
Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review | Q34778408 | ||
Antibody response to influenza vaccination in the elderly: a quantitative review | Q36280602 | ||
Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains | Q36854011 | ||
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses | Q37416103 | ||
Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia | Q38275284 | ||
The test-negative design for estimating influenza vaccine effectiveness | Q38427246 | ||
Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital | Q39525235 | ||
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. | Q39961932 | ||
Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003. | Q40521075 | ||
Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014 | Q42182563 | ||
Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. | Q42227573 | ||
Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match | Q42244861 | ||
Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project, 2010-2011. | Q42249065 | ||
The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials | Q42265788 | ||
Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. | Q44243917 | ||
DAGitty: a graphical tool for analyzing causal diagrams | Q44636307 | ||
Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants | Q45167252 | ||
Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required | Q45375388 | ||
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season | Q46159620 | ||
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season | Q47843797 | ||
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. | Q50801938 | ||
The case test-negative design for studies of the effectiveness of influenza vaccine. | Q51225150 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | influenza vaccine | Q383260 |
P304 | page(s) | 1070-1076 | |
P577 | publication date | 2016-01-12 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach. | |
P478 | volume | 34 |
Q93089924 | A framework for research on vaccine effectiveness |
Q92915035 | Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort |
Q29994560 | Case-control vaccine effectiveness studies: Data collection, analysis and reporting results |
Q40172861 | Development and identification of a new Vero cell-based live attenuated influenza B vaccine by a modified classical reassortment method |
Q57100369 | Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study |
Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Q47160827 | Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada |
Q98302223 | Vaccine effectiveness against laboratory-confirmed influenza in Europe - Results from the DRIVE network during season 2018/19 |
Search more.